PT Kalbe Farma Tbk (KLBF) - Financial and Strategic SWOT Analysis Review

PT Kalbe Farma Tbk (KLBF) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

PT Kalbe Farma Tbk (Kalbe) provides healthcare solutions to its customers. The company focuses on the development, manufacturing and distribution of prescription pharmaceutical products, consumer health products, nutritional products, and healthcare services. Its product portfolio comprises branded and unbranded generic drugs, nutritional products and supplements, over-the-counter (OTC) drugs, energy drinks, and medical testing kits among others. Kalbe is involved in the marketing and trading of medical devices and provides distribution and logistics solutions for pharmaceutical products in Indonesia. It has overseas branches and representative offices in ASEAN countries, Nigeria, the Philippines, and Singapore. The company serves hospitals, pharmacies, and drug stores across Indonesia. Kalbe is headquartered in Jakarta, Indonesia.

PT Kalbe Farma Tbk Key Recent Developments

Mar 05,2023: Kalventis conduct the 2023 Indonesia Diabetes Leadership Summit with the Ministry of Health and PERKENI
Jan 16,2023: Kalbe and its innovations, an effort to improve the pharmaceutical industry in Indonesia

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
PT Kalbe Farma Tbk - Key Facts
PT Kalbe Farma Tbk - Key Employees
PT Kalbe Farma Tbk - Major Products and Services
PT Kalbe Farma Tbk - History
PT Kalbe Farma Tbk - Company Statement
PT Kalbe Farma Tbk - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
PT Kalbe Farma Tbk - Business Description
Business Segment: Consumer Health
Overview
Performance
Business Segment: Distribution and Logistics
Overview
Performance
Business Segment: Nutritionals
Overview
Performance
Business Segment: Prescription Pharmaceuticals
Overview
Performance
Geographical Segment: Domestic
Performance
Geographical Segment: Export
Performance
R&D Overview
PT Kalbe Farma Tbk - Corporate Strategy
PT Kalbe Farma Tbk - SWOT Analysis
SWOT Analysis - Overview
PT Kalbe Farma Tbk - Strengths
PT Kalbe Farma Tbk - Weaknesses
PT Kalbe Farma Tbk - Opportunities
PT Kalbe Farma Tbk - Threats
PT Kalbe Farma Tbk - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
PT Kalbe Farma Tbk, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 05, 2023: Kalventis conduct the 2023 Indonesia Diabetes Leadership Summit with the Ministry of Health and PERKENI
Jan 16, 2023: Kalbe and its innovations, an effort to improve the pharmaceutical industry in Indonesia
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
PT Kalbe Farma Tbk, Key Facts
PT Kalbe Farma Tbk, Key Employees
PT Kalbe Farma Tbk, Major Products and Services
PT Kalbe Farma Tbk, History
PT Kalbe Farma Tbk, Other Locations
PT Kalbe Farma Tbk, Subsidiaries
PT Kalbe Farma Tbk, Joint Venture
PT Kalbe Farma Tbk, Key Competitors
PT Kalbe Farma Tbk, Ratios based on current share price
PT Kalbe Farma Tbk, Annual Ratios
PT Kalbe Farma Tbk, Annual Ratios (Cont...1)
PT Kalbe Farma Tbk, Annual Ratios (Cont...2)
PT Kalbe Farma Tbk, Interim Ratios
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
PT Kalbe Farma Tbk, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
PT Kalbe Farma Tbk, Performance Chart (2019 - 2023)
PT Kalbe Farma Tbk, Ratio Charts
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings